Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
The relationship between plaque pathology and disease duration was examined in 15 patients with multiple sclerosis who died early in the course of their illness. Myelin-stained sections revealed that most plaques examined in patients who died during the first month of their illness showed evidence of ongoing myelin destruction accompanied by a loss of oligodendrocytes. Plaques containing large numbers of oligodendrocytes were not observed in these patients, but were relatively common in patients who died more than 1 month after clinical onset. Remyelination affecting more than 10% of the plaque area was observed in 3 of 82 plaques in 5 patients who died within 10 weeks of clinical onset, in 38 of 105 plaques in 5 patients who died 3 to 10 months after clinical onset, and in 19 of 92 plaques in 5 patients who died 18 months or longer after clinical onset. The study provides new evidence that both oligodendrocytes and myelin are destroyed in new lesions, that this activity ceases completely in many lesions within a few weeks, and that remyelination frequently ensues following repopulation of the plaque by oligodendrocytes. The findings suggest that new lesions normally remyelinate unless interrupted by recurrent activity and that remyelinated shadow plaques are the outcome of a single previous episode of focal demyelination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For cortical grey matter, this now indicates that oligodendrocyte recruitment and remyelination is an early phenomenon in MS lesion formation that occurs in the immediate post-phagocytic phase when foam cells are still abundant in the demyelinated lesions.56-60”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [57]
In the citing paper
“However, despite remyelination being very efficient at the early stages of the disease, this process gradually fails over time [115,116].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [115]
Citations
Cites
Handbook of clinical neurology
(1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90030-5 · Cited by 1,849
Lantos, P. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.496 · Cited by 1,152
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Payne, J. P. (1969) · British Journal of Anaesthesia · doi:10.1093/bja/41.4.356 · Cited by 600
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Self-citationRemyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
ULTRASTRUCTURAL STUDY OF REMYELINATION IN AN EXPERIMENTAL LESION IN ADULT CAT SPINAL CORD
Bunge, M. B., Bunge, R. P., & Ris, H. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.10.1.67 · Cited by 396
Proliferating bipotential glial progenitor cells in adult rat optic nerve
ffrench-Constant, C., & Raff, M. C. (1986) · Nature · doi:10.1038/319499a0 · Cited by 385
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Pathology of the Nervous System
Krigman, M. R. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03160150057026 · Cited by 286
Research works printed but not linked: 3
- Schlesinger H, 1909, Zur Frage der akuten multiplen Sklerose und der Enzephalomyelitis disseminata im Kindesalter, Arch Neurol Inst, Wien, 17, 410
- Greenfield JG, 1958, Neuropathology, 441
- Jacob H, 1969, Tissue process in multiple sclerosis and parainfectious and post‐vaccinal encephalomyelitis, Int Arch Allergy Appl Immunol, 36, 22
Cited by
Items 201–300 of 571
Stem cells, progenitors and myelin repair
Zhao, C., Fancy, S. P. J., Magy, L., Urwin, J. E., & Franklin, R. J. M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00456.x · Cited by 61
“…an event that makes a significant contribution to the progressive phase of MS (De Stefano et al. 1998; Bjartmar et al. 2003), or new myelin sheaths can be restored to the demyelinated axons in a spontaneous regenerative process called remyelination (Prineas et al. 1993; Lassmann et al. 1997).”
BackgroundMyelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse
Li, M., Shibata, A., Li, C., Braun, P. E., McKerracher, L., Roder, J., Kater, S. B., & David, S. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961115)46:4<404::aid-jnr2>3.0.co;2-k · Cited by 191
Franklin, R. J., & Blakemore, W. F. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300205 · Cited by 59
Brusa, A., Jones, S., Kapoor, R., Miller, D. H., & Plant, G. T. (1999) · Journal of Neurology · doi:10.1007/s004150050454 · Cited by 59
Chu, T., Shields, L. B. E., Zhang, Y. P., Feng, S., Shields, C. B., & Cai, J. (2017) · The Neuroscientist · doi:10.1177/1073858416685690 · Cited by 65
Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis
Xiao, J., Yang, R., Biswas, S., Zhu, Y., Qin, X., Zhang, M., Zhai, L., Luo, Y., He, X., Mao, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0566-7 · Cited by 62
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination
Zeldich, E., Chen, C.-D., Avila, R. L., Medicetty, S., & Abraham, C. R. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0598-2 · Cited by 63
Cytokines, Signal Transduction, and Inflammatory Demyelination: Review and Hypothesis
Ledeen, R. W., & Chakraborty, G. (1998) · Neurochemical Research · doi:10.1023/a:1022493013904 · Cited by 68
Bates, I. R., Libich, D. S., Wood, D. D., Moscarello, M. A., & Harauz, G. (2002) · Protein Expression and Purification · doi:10.1016/s1046-5928(02)00017-7 · Cited by 58
Bromodomains: Translating the words of lysine acetylation into myelin injury and repair
Ntranos, A., & Casaccia, P. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.015 · Cited by 63
van Engelen, B. G. M., Miller, D. J., Pavelko, K. D., Hommes, O. R., & Rodriguez, M. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.suppl.65 · Cited by 59
Stangel, M., Boegner, F., Klatt, C. H., Hofmeister, C., & Seyfert, S. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.1.89 · Cited by 58
The Insulin‐like Growth Factor System in Multiple Sclerosis
Chesik, D., Wilczak, N., & Keyser, J. D. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79009-8 · Cited by 58
Mancuso, R., Hernis, A., Agostini, S., Rovaris, M., Caputo, D., & Clerici, M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0504-2 · Cited by 57
Dynamic response of microglia/macrophage polarization following demyelination in mice
Chu, T., Zhang, Y. P., Tian, Z., Ye, C., Zhu, M., Shields, L. B. E., Kong, M., Barnes, G. N., Shields, C. B., & Cai, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1586-1 · Cited by 58
Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?
Liu, C., Playford, E. D., & Thompson, A. J. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0187-0 · Cited by 54
Shields, S. A., Gilson, J. M., Blakemore, W. F., & Franklin, R. J. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199910)28:1<77::aid-glia9>3.0.co;2-f · Cited by 287
Butt, A. M., & Jenkins, H. G. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90125-2 · Cited by 55
“Focal demyelination and the destruction of oligodendrocytes in the central nervous system (CNS) is a prominent pathological feature of multiple sclerosis (Prineas et al., 1989, 1993), although the mechanism for these changes remains to be determined.”
BackgroundTaking ageing into account in remyelination-based therapies for multiple sclerosis
Rist, J. M., & Franklin, R. J. M. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.027 · Cited by 58
Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis
Lai, H. M., Davie, C. A., Gass, A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., McDonald, W. I., & Miller, D. H. (1997) · Journal of Neurology · doi:10.1007/s004150050092 · Cited by 56
Lankford, K. L., Imaizumi, T., Honmou, O., & Kocsis, J. D. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10117 · Cited by 52
“…1966; Feigin and Ogata, 1971; Ghatak et al., 1973; Ogata and Feigin, 1975; Prineas and Collenil, 1979; Itoyama et al., 1983, 1985; Rodriguez, 1992; Prineas et al., 1993) and CNS trauma (Hughes and Brownel, 1963; Harrison and McDonald, 1977; Griffiths and McCulloch, 1983; Perry and Hayes, 1985;…”
Backgroundvan Gelder, M., Mulder, A. H., & van Bekkum, D. W. (1996) · Transplantation · doi:10.1097/00007890-199609270-00019 · Cited by 52
The electrophysiological assessment of visual function in Multiple Sclerosis
Barton, J., Garber, J. Y., Klistorner, A. I., & Barnett, M. H. (2019) · Clinical Neurophysiology Practice · doi:10.1016/j.cnp.2019.03.002 · Cited by 58
The Controversy Surrounding the Pathogenesis of the Multiple Sclerosis Lesion
Lucchinetti, C. F., & Rodriguez, M. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.7.665 · Cited by 56
Carlström, K. E., Zhu, K., Ewing, E., Krabbendam, I. E., Harris, R. A., Falcão, A. M., Jagodic, M., Castelo‐Branco, G., & Piehl, F. (2020) · Nature Communications · doi:10.1038/s41467-020-17871-5 · Cited by 53
Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells
Sharp, J., & Keirstead, H. S. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.006 · Cited by 55
Cell transplantation, myelin repair, and multiple sclerosis
Halfpenny, C. A., Benn, T., & Scolding, N. J. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00004-2 · Cited by 56
Mechanisms of action of interferon-β in multiple sclerosis
Arnason, B. G. W., Dayal, A. S., Qu, Z. X., Jensen, M. A., Genç, K., & Reder, A. T. (1996) · Springer eBooks · doi:10.1007/978-3-642-61191-9_18 · Cited by 49
Cell Therapy for Multiple Sclerosis
Ben‐Hur, T. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0073-x · Cited by 51
Mohan, H., Friese, A., Albrecht, S., Krumbholz, M., Elliott, C. L., Arthur, A., Menon, R., Farina, C., Junker, A., Stadelmann, C., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0168-9 · Cited by 49
Ciotti, J. R., Eby, N. S., Wu, G. F., Naismith, R. T., Chahin, S., & Cross, A. H. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102399 · Cited by 55
McLaurin, J., & Yong, V. W. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30060-4 · Cited by 64
Kidd, D. P. (1998) · Brain · doi:10.1093/brain/121.6.1109 · Cited by 51
“Although remyelination occurs in multiple sclerosis, and may be more extensive than previously supposed (Prineas et al., 1993), it is clear that recovery of function can occur despite persistent demyelination, as shown by relatively normal vision in the presence of persistent delays in the visual…”
BackgroundLin, Y., Huang, G., Jamison, S., Li, J., Harding, H. P., Ron, D., & Lin, W. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.009 · Cited by 52
Olig1 is expressed in human oligodendrocytes during maturation and regeneration
Othman, A. H., Frim, D. M., Polak, P. E., Vujicic, S., Arnason, B. G. W., & Boullerne, A. I. (2011) · Glia · doi:10.1002/glia.21163 · Cited by 55
“Remyelination does occur occasionally at the lesion edges and in rare ‘‘shadow’’ plaques (Patrikios et al., 2006; Prineas et al., 1993).”
BackgroundYong, V. W., Dooley, N. P., & Noble, P. G. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390111 · Cited by 59
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia
Mecha, M., Yanguas-Casás, N., Feliú, A., Mestre, L., Carrillo-Salinas, F., Azcoitia, I., Yong, V. W., & Guaza, C. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.12.013 · Cited by 47
“A hallmark of the remyelination in MS is the so-called shadow plaques, where myelin staining lies is interspersed between the demyelinated plaques and the normal white matter (Prineas et al., 1993; Plemel et al., 2017).”
BackgroundProspects of Cell Therapy for Disorders of Myelin
Ben‐Hur, T., & Goldman, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.014 · Cited by 47
Abromson‐Leeman, S. R., Bronson, R. T., Luo, Y., Berman, M. A., Leeman‐Neill, R. J., Leeman, J. R., & Dorf, M. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63410-4 · Cited by 48
Pathogenesis of Brain and Spinal Cord Atrophy in Multiple Sclerosis
Minagar, A., Toledo, E. G., Alexander, J. S., & Kelley, R. E. (2004) · Journal of Neuroimaging · doi:10.1177/1051228404266263 · Cited by 57
Multiple sclerosis: Immune mechanism and update on current therapies
Bansil, S., Cook, S. D., & Rohowsky‐Kochan, C. (1995) · Annals of Neurology · doi:10.1002/ana.410370710 · Cited by 54
Archelos, J. J., & Hartung, H. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01066-6 · Cited by 47
van Waesberghe, J. H. T., Castelijns, J. A., Scheltens, P., Truyen, L., Nijeholt, G. J. L. À., Hoogenraad, F. G. C., Polman, C. H., Valk, J., & Barkhof, F. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00340-2 · Cited by 47
Al‐Ubaidi, M. R., White, T. W., Ripps, H., Poras, I., Avner, P., Gomès, D., & Bruzzone, R. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000315)59:6<813::aid-jnr14>3.0.co;2-# · Cited by 109
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Stys, P. K. (2013) · F1000Prime Reports · doi:10.12703/p5-20 · Cited by 46
Beniac, D. R., Wood, D. D., Palaniyar, N., Ottensmeyer, F. P., Moscarello, M. A., & Harauz, G. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0111 · Cited by 46
Khalaj, A. J., Hasselmann, J., Augello, C., Moore, S., & Tiwari-Woodruff, S. K. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.01.006 · Cited by 44
Remyelination of optic nerve lesions: spatial and temporal factors
Klistorner, A. I., Arvind, H., Garrick, R., Yiannikas, C., Paine, M., & Graham, S. L. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510371408 · Cited by 48
Stem cell based delivery of IFN-β reduces relapses in experimental autoimmune encephalomyelitis
Makar, T. K., Trisler, D. N., Bever, C. T., Goolsby, J. E., Sura, K. T., Balasubramanian, S., Sultana, S., Patel, N. C., Ford, D., Singh, I. S., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.02.014 · Cited by 47
Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo
Butt, A. M., & Dinsdale, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.007 · Cited by 55
Takahashi, C., Muramatsu, R., Fujimura, H., Mochizuki, H., & Yamashita, T. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.335 · Cited by 44
Relapses in multiple sclerosis: effects of high‐dose steroids on cortical excitability
Ayache, S. S., Créange, A., Farhat, W. H., Zouari, H. G., Mylius, V., Ahdab, R., Abdellaoui, M., & Lefaucheur, J. P. (2014) · European Journal of Neurology · doi:10.1111/ene.12356 · Cited by 45
Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination
Watzlawik, J. O., Warrington, A. E., & Rodriguez, M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.13 · Cited by 53
Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions
Prineas, J. W., & Lee, S. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly121 · Cited by 44
Self-citationPathology of inflammatory diseases of the nervous system: Human disease versus animal models
Lassmann, H. (2020) · Glia · doi:10.1002/glia.23726 · Cited by 44
Role of Endogenous Neural Stem Cells in Neurological Disease and Brain Repair
Dietrich, J., & Kempermann, G. (2007) · Springer eBooks · doi:10.1007/0-387-30128-3_12 · Cited by 50
Remyelination in multiple sclerosis: a new role for neurotrophins?
Althaus, H. H. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46026-3 · Cited by 51
Huang, S., Ding, Y., Ruan, J., Zhang, W., Wu, J., He, B., Zhang, Y., Li, Y., & Zeng, Y. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.03.010 · Cited by 46
Eliprodil stimulates CNS myelination: New prospects for multiple sclerosis?
Demerens, C., Stankoff, B., Zalc, B., & Lubetzki, C. (1999) · Neurology · doi:10.1212/wnl.52.2.346 · Cited by 44
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
Abu-Rub, M., & Miller, R. H. (2018) · Brain Sciences · doi:10.3390/brainsci8060111 · Cited by 50
Paintlia, A. S., Paintlia, M. K., Singh, A. K., Orak, J. K., & Singh, I. (2010) · Glia · doi:10.1002/glia.21039 · Cited by 43
“Neurological deficits usually disap- pear in MS patients by spontaneous remyelination of axons by myelinating OLs present in acute lesions, while they persist in some patients due to failed remyelination especially in chronic lesions (Jeffery and Blakemore, 1997; Prineas et al., 1993).”
BackgroundPiao, J., Wang, Y., & Duncan, I. D. (2012) · Glia · doi:10.1002/glia.22438 · Cited by 49
“Although it is known that endogenous remyelination is extensive in early disease (Patani et al., 2007; Patrikios et al., 2006; Prineas et al., 1993; Prineas and Connell 1979; Raine and Wu 1993), remyelination eventually becomes less robust (Goldschmidt et al., 2009) as a result of a lack of…”
BackgroundCarlin, C., Murray, L., Graham, D., Doyle, D., & Nicoll, J. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.5.361 · Cited by 43
Imitola, J., Snyder, E. Y., & Khoury, S. J. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00021.2002 · Cited by 49
Brain lipid binding protein (FABP7) as modulator of astrocyte function
KIPP, M., CLARNER, T., GINGELE, S., POTT, F., AMOR, S., VAN DER VALK, P., & BEYER, C. (2011) · Physiological Research · doi:10.33549/physiolres.932168 · Cited by 42
“The loss and destruction of OPC within the lesions in the course of repeated de- and remyelination (Prineas et al. 1993a, Prineas et al. 1993b) might play a role.”
BackgroundCurrent concepts of the cellular and molecular pathophysiology of multiple sclerosis
Greenstein, J. I. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20387 · Cited by 49
“There is a loss of myelin and oligodendroglia as well as axons within the lesion (Prineas et al., 1993; Ferguson et al., 1997; Trapp et al., 1998).”
Clinical implications of neuropathological findings in multiple sclerosis
Brück, W. (2005) · Journal of Neurology · doi:10.1007/s00415-005-2011-5 · Cited by 48
Myelin Repair: From Animal Models to Humans
Cayre, M., Falque, M., Mercier, O., Magalon, K., & Durbec, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.604865 · Cited by 48
“Many studies have suggested that remyelination is more prominent at the beginning of the disease than in chronic MS, in which the extent of remyelination is often limited (Prineas et al., 1993; Goldschmidt et al., 2009; Chen et al., 2013; Frischer et al., 2015).”
BackgroundImprovement in Conduction Velocity after Optic Neuritis Measured with the Multifocal VEP
Yang, E. B., Hood, D. C., Rodarte, C., Zhang, X., Odel, J. G., & Behrens, M. M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0475 · Cited by 42
Growth factor treatment of demyelinating disease: at last, a leap into the light
Ransohoff, R. M., Howe, C. L., & Rodriguez, M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02321-9 · Cited by 45
New insights into the pathophysiology of primary hemifacial spasm
Lefaucheur, J. P. (2018) · Neurochirurgie · doi:10.1016/j.neuchi.2017.12.004 · Cited by 42
Moscarello, M. A., Mak, B. C., Nguyen, T. A., Wood, D. D., Mastronardi, F. G., & Ludwin, S. K. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms776oa · Cited by 48
Monteros, A. E. D. L., Zhao, P. M., Huang, C. J., Pan, T., Chang, R., Nazarian, R., Espejo, D., & de Vellis, J. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971201)50:5<872::aid-jnr23>3.0.co;2-1 · Cited by 39
Optic neuritis in multiple sclerosis
Chan, J. W. (2002) · Ocular Immunology and Inflammation · doi:10.1076/ocii.10.3.161.15603 · Cited by 39
Diffusion imaging in multiple sclerosis
Bammer, R., & Fazekas, F. (2002) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00071-6 · Cited by 41
CNTF-Activated Astrocytes Release a Soluble Trophic Activity for Oligodendrocyte Progenitors
Albrecht, P. J., Enterline, J. C., Cromer, J. A., & Levison, S. W. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9151-6 · Cited by 47
Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis
Hatch, M. N., Schaumburg, C. S., Lane, T. E., & Keirstead, H. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.002 · Cited by 39
“Regeneration and remyelination of these damaged lesions can spontaneously occur with a range of efficiencies (Patrikios et al., 2006; Prineas et al., 1993; Raine andWu,1993), and is presumably triggered by the repopulation of regions of demyelination with myelin producing oligodendrocyte progenitor…”
BackgroundOptic neuritis: A mechanistic view
Burton, E. V., Greenberg, B. M., & Frohman, E. M. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.009 · Cited by 42
The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?
Pender, M. P. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2003.12.013 · Cited by 43
Ibudilast for the treatment of multiple sclerosis
Goodman, A. D., Gyang, T. V., & Smith, A. D. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1221924 · Cited by 39
Yoshioka, A., Yamaya, Y., Saiki, S., Kanemoto, M., Hirose, G., & Pleasure, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740633.x · Cited by 38
“Excitotoxicity has been implicated in oligodendroglial depletion from foci of CNS ischemia or inflammation (Leifer et al., 1990; Giulian et al., 1993; Prineas et al., 1993; Raine and Wu, 1993; Wender and Szczech, 1994).”
BackgroundMolecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases
Ohtomo, R., Iwata, A., & Arai, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061743 · Cited by 40
Central Nervous System Remyelination Clinical Application of Basic Neuroscience Principles
Miller, D. J., Asakura, K., & Rodriguez, M. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00859.x · Cited by 35
Nerve growth factor signal transduction in mature pig oligodendrocytes
Althaus, H. H., Hempel, R., Kl�ppner, S., Engel, J., Schmidt‐Schultz, T. H., Kruska, L., & Heumann, R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971201)50:5<729::aid-jnr10>3.0.co;2-x · Cited by 38
Slowly eroding lesions in multiple sclerosis
Sethi, V., Nair, G., Absinta, M., Sati, P., Venkataraman, A., Ohayon, J., Wu, T., Yang, K., Shea, C., Dewey, B. E., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516655403 · Cited by 34
FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination
Kipp, M., & Amor, S. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438723 · Cited by 37
van der Walt, A., Kolbe, S., Mitchell, P., Wang, Y., Butzkueven, H., Egan, G. F., Yiannikas, C., Graham, S. L., Kilpatrick, T. J., & Klistorner, A. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121084 · Cited by 36
Multifocal VEP assessment of optic neuritis evolution
Alshowaeir, D., Yiannikas, C., Garrick, R., van der Walt, A., Graham, S. L., Fraser, C. L., & Klistorner, A. I. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.11.010 · Cited by 33
Genetically Dominant Spinal Cord Repair in a Murine Model of Chronic Progressive Multiple Sclerosis
Bieber, A. J., Ure, D. R., & Rodriguez, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.46 · Cited by 33
Choi, H. B., Hong, S. H., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2003) · Glia · doi:10.1002/glia.10239 · Cited by 35
“…been implicated in various neurological diseases such as Parkinson’s disease (PD) (McGeer et al., 1988; Gao et al., 2002), multiple sclerosis (MS) (Prineas et al., 1993; Copelman et al., 2001), Alzheimer’s disease (AD) (Tooyama et al., 1990; Lue et al., 2001), and amyotrophic lateral sclerosis…”
BackgroundSegal, B. M., Raine, C. S., McFarlin, D. E., Voskuhl, R. R., & McFarland, H. F. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90123-6 · Cited by 34
“In addition, remyelination has been found in fresh MS plaques, potentially providing a source of newly formed exon 2-containing isoforms, analogous to the mechanism proposed in our murine model (Prineas et al., 1993; Raine et al., 1993).”
Njenga, M. K., Murray, P. D., McGavern, D., Lin, X., Drescher, K. M., & Rodriguez, M. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199901000-00009 · Cited by 33
Pathology of the myelin sheath
Ludwin, S. K. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195082937.003.0022 · Cited by 33
Rosengren, S. M., Nogajski, J. H., Cremer, P. D., & Colebatch, J. G. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.05.068 · Cited by 32
Gender differences in the histopathology of MS?
Kuhlmann, T., GOLDSCHMIDT, T. J., Antel, J. P., Wegner, C., König, F. B., Metz, I., & Brück, W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.014 · Cited by 38
Boukhvalova, M. S., Mortensen, E., Mbaye, A., Lopez, D., Kastrukoff, L. F., & Blanco, J. C. G. (2019) · Journal of Virology · doi:10.1128/jvi.01161-19 · Cited by 32
Cerri, G., Montagna, M., Madaschi, L., Merli, D., BORRONI, P. F., Baldissera, F. G., & Gorio, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.041 · Cited by 34
“It is well known that demyelinated axons can be repaired by re-myelination (Prineas et al., 1993) and re-myelination has been demonstrated to restore a sufficiently secure conduction (Felts and Smith, 1992; Honmou et al., 1996; Akiyama et al., 2002).”
BackgroundInterferon-beta inhibits mitogen induced astrocyte proliferation in vitro
Malik, O., Compston, D. A. S., & Scolding, N. J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00049-6 · Cited by 33
“Spontaneous remyelination does occur in MS but is not usually sustained, presumably Ždue to repeated inflammatory damage Prineas et al., 1993; .”
BackgroundD’Mello, S. R., Kuan, C.-Y., Flavell, R. A., & RAKIC, P. T. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000101)59:1<24::aid-jnr4>3.0.co;2-8 · Cited by 107
Solanky, M., Maeda, Y., Ming, X., Husar, W., Li, W., Cook, S., & Dowling, P. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1155 · Cited by 31
“…that remyelination is often a prominent feature of early MS plaques, and large numbers of oligodendrocytes in excess of those within normal white matter are encountered in these early MS lesions (Raine et al., 1981; Lassmann, 1983; Prineas et al., 1993; Brück et al., 1994; Lassmann et al., Fig.”
Background
Metadata
- Authors
- Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐.
- Affiliations
- East Orange VA Medical Center (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Prineas, J. W.
- ORCID
- Prineas, J. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-02
- Volume
- 33
- Issue
- 2
- Pages
- 137-151
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2024751716
- Cited by
- 574
- References
- 46
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 14 · 2014: 18 · 2013: 13 · 2012: 16
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, remyelination, demyelination, oligodendrocytes, myelin destruction, disease duration, early-onset multiple sclerosis
- MeSH terms
- Adolescent, Adult, Aged, Axons, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Regeneration, Oligodendroglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.